Improved prediction of prognosis and therapy response for lung adenocarcinoma after identification of DNA-directed RNA polymerase-associated lncRNAs

被引：0
|
作者：
Jiaao Yu
Liqiang Lan
Caixin Liu
Xiao Zhu
机构：
[1] The First Affiliated Hospital of Wannan Medical College,Clinical Laboratory
[2] The Marine Biomedical Research Institute,Computational Systems Biology Lab (CSBL), Institute of Bioinformatics
[3] Guangdong Medical University,Department of Internal Medicine
[4] Qingdao Sixth People’s Hospital,undefined
[5] Zhejiang Provincial People’s Hospital,undefined
[6] People’s Hospital of Hangzhou Medical College,undefined
[7] Hangzhou Medical College,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Lung adenocarcinoma; lncRNAs; DNA-directed RNA polymerase; Drug sensitivity; Immunotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：12737 / 12754
页数：17
相关论文
共 37 条
  • [31] Comprehensive analysis of single-cell RNA and bulk RNA sequencing based on M2 tumor-associated macrophage and angiogenesis-related genes to assess prognosis and therapeutic response in lung adenocarcinoma
    Liu, Anbang
    Liu, Gengqiu
    Wang, Xiaohuai
    Yan, Dongqing
    Zhang, Junhang
    Wei, Li
    HELIYON, 2024, 10 (14)
  • [32] Identification and Validation of a Novel Signature Based on NK Cell Marker Genes to Predict Prognosis and Immunotherapy Response in Lung Adenocarcinoma by Integrated Analysis of Single-Cell and Bulk RNA-Sequencing
    Song, Peng
    Li, Wenbin
    Guo, Lei
    Ying, Jianming
    Gao, Shugeng
    He, Jie
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [33] Identification of an antigen-presenting cells/T/NK cells-related gene signature to predict prognosis and CTSL to predict immunotherapeutic response for lung adenocarcinoma: an integrated analysis of bulk and single-cell RNA sequencing
    Huang, Liling
    Lou, Ning
    Xie, Tongji
    Tang, Le
    Han, Xiaohong
    Shi, Yuankai
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (10) : 3259 - 3277
  • [34] Identification of an antigen-presenting cells/T/NK cells-related gene signature to predict prognosis and CTSL to predict immunotherapeutic response for lung adenocarcinoma: an integrated analysis of bulk and single-cell RNA sequencing
    Liling Huang
    Ning Lou
    Tongji Xie
    Le Tang
    Xiaohong Han
    Yuankai Shi
    Cancer Immunology, Immunotherapy, 2023, 72 : 3259 - 3277
  • [35] Quantitative Model Analysis and Simulation of Pharmacokinetics and Metastasis-Associated Lung Adenocarcinoma 1 RNA Knockdown Effect After Systemic Administration of Cholesterol-Conjugated DNA/RNA Heteroduplex Oligonucleotide Crossing Blood-Brain Barrier of Mice
    Goto, Akihiko
    Yamamoto, Syunsuke
    Igari, Tomoko
    Matsumoto, Shin-ichi
    Chisaki, Ikumi
    Iida, Koichi
    Nakayama, Miyu
    Oda, Akira
    Kakoi, Yuuichi
    Uchida, Akio
    Miyata, Kenichi
    Nishikawa, Makiya
    Nagata, Tetsuya
    Kusuhara, Hiroyuki
    Yokota, Takanori
    Hirabayashi, Hideki
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 384 (01): : 197 - 204
  • [36] Identification of an antigen-presenting cells/T/NK cells-related gene signature to predict prognosis and gene marker CTSL to predict immunotherapeutic response for lung adenocarcinoma: An integrated analysis of bulk and single cell RNA sequencing
    Huang, L.
    Xie, T.
    Shi, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S140 - S140
  • [37] Identification of gene signatures associated with response in a Phase II trial of entinostat (ENT) plus pembrolizumab (PEMBRO) in non-small cell lung cancer (NSCLC) patients whose disease has progressed on or after anti-PD-(L)1 therapy
    Ordentlich, Peter
    Wang, Lei
    Tamang, David
    Sullivan, Amy H.
    Church, Sally E.
    Rozelle, Dan
    Meyers, Michael L.
    Ramalingam, Suresh S.
    Hellmann, Matthew D.
    CANCER RESEARCH, 2019, 79 (13)
1234